TABLE 2.
Estimated Proportion of All-Cause Mortality Attributable to Obesity, by Country, Age, and Sex
| Women |
Men |
|||||||
| Country | 50–59 Years, PAF (95% CI) | 60–69 Years, PAF (95% CI) | 70–79 Years, PAF (95% CI) | 80–89 Years, PAF (95% CI) | 50–59 Years, PAF (95% CI) | 60–69 Years, PAF (95% CI) | 70–79 Years, PAF (95% CI) | 80–89 Years, PAF (95% CI) |
| Estimates based on self-reported height and weight | ||||||||
| Comparison countries | ||||||||
| Austria | 0.13 (0.10, 0.19) | 0.18 (0.13, 0.23) | 0.08 (0.06, 0.14) | 0.06 (0.02, 0.16) | 0.19 (0.15, 0.23) | 0.13 (0.10, 0.16) | 0.10 (0.07, 0.13) | 0.05 (0.00, 0.12) |
| Belgium | 0.09 (0.07, 0.15) | 0.16 (0.11, 0.20) | 0.10 (0.08, 0.15) | 0.06 (0.02, 0.17) | 0.16 (0.13, 0.20) | 0.12 (0.09, 0.15) | 0.10 (0.07, 0.13) | 0.07 (0.00, 0.14) |
| Czech Republic | 0.10 (0.07, 0.17) | 0.19 (0.13, 0.25) | 0.14 (0.10, 0.21) | 0.07 (0.02, 0.18) | 0.18 (0.14, 0.22) | 0.16 (0.12, 0.20) | 0.12 (0.08, 0.15) | 0.09 (0.00, 0.17) |
| Denmark | 0.08 (0.06, 0.13) | 0.11 (0.06, 0.14) | 0.09 (0.07, 0.15) | 0.03 (0.01, 0.14) | 0.13 (0.10, 0.17) | 0.11 (0.08, 0.14) | 0.07 (0.05, 0.10) | 0.06 (0.00, 0.13) |
| France | 0.08 (0.06, 0.14) | 0.12 (0.08, 0.17) | 0.08 (0.06, 0.14) | 0.04 (0.01, 0.15) | 0.15 (0.11, 0.19) | 0.13 (0.09, 0.17) | 0.10 (0.07, 0.13) | 0.06 (0.00, 0.13) |
| Germany | 0.09 (0.08, 0.15) | 0.16 (0.11, 0.21) | 0.11 (0.09, 0.17) | 0.05 (0.01, 0.15) | 0.15 (0.12, 0.19) | 0.13 (0.11, 0.16) | 0.11 (0.08, 0.14) | 0.08 (0.00, 0.15) |
| Israel | 0.10 (0.06, 0.18) | 0.14 (0.09, 0.19) | 0.15 (0.10, 0.22) | 0.05 (0.00, 0.15) | 0.15 (0.10, 0.21) | 0.13 (0.09, 0.18) | 0.11 (0.06, 0.17) | 0.05 (0.00, 0.12) |
| Italy | 0.09 (0.07, 0.15) | 0.14 (0.10, 0.19) | 0.09 (0.07, 0.15) | 0.05 (0.01, 0.16) | 0.14 (0.11, 0.18) | 0.13 (0.10, 0.16) | 0.10 (0.07, 0.13) | 0.07 (0.00, 0.14) |
| Netherlands | 0.10 (0.08, 0.16) | 0.13 (0.08, 0.18) | 0.11 (0.08, 0.17) | 0.05 (0.01, 0.14) | 0.13 (0.10, 0.16) | 0.13 (0.10, 0.15) | 0.07 (0.05, 0.10) | 0.04 (0.00, 0.11) |
| Poland | 0.14 (0.11, 0.21) | 0.22 (0.16, 0.27) | 0.16 (0.13, 0.22) | 0.06 (0.02, 0.17) | 0.16 (0.13, 0.21) | 0.16 (0.13, 0.20) | 0.10 (0.08, 0.13) | 0.06 (0.00, 0.12) |
| Spain | 0.12 (0.10, 0.19) | 0.21 (0.15, 0.27) | 0.14 (0.11, 0.20) | 0.09 (0.03, 0.18) | 0.18 (0.14, 0.23) | 0.15 (0.12, 0.18) | 0.11 (0.08, 0.14) | 0.09 (0.00, 0.16) |
| Sweden | 0.09 (0.07, 0.16) | 0.13 (0.08, 0.17) | 0.10 (0.08, 0.16) | 0.05 (0.02, 0.16) | 0.16 (0.10, 0.24) | 0.11 (0.09, 0.14) | 0.08 (0.06, 0.10) | 0.04 (0.00, 0.10) |
| Switzerland | 0.06 (0.04, 0.10) | 0.11 (0.07, 0.16) | 0.09 (0.06, 0.14) | 0.05 (0.01, 0.14) | 0.14 (0.11, 0.18) | 0.11 (0.08, 0.15) | 0.09 (0.06, 0.13) | 0.06 (0.00, 0.13) |
| Average | 0.10 (0.08, 0.15) | 0.15 (0.11, 0.20) | 0.11 (0.09, 0.17) | 0.05 (0.02, 0.16) | 0.16 (0.13, 0.19) | 0.13 (0.11, 0.16) | 0.10 (0.07, 0.12) | 0.06 (0.00, 0.12) |
| United States | 0.20 (0.17, 0.27) | 0.23 (0.18, 0.28) | 0.14 (0.12, 0.19) | 0.06 (0.03, 0.16) | 0.24 (0.21, 0.29) | 0.21 (0.18, 0.24) | 0.14 (0.11, 0.17) | 0.07 (0.00, 0.13) |
| Estimates based on measured height and weight | ||||||||
| Comparison countries | ||||||||
| Canada | 0.15 (0.12, 0.22) | 0.26 (0.20, 0.33) | 0.14 (0.11, 0.20) | 0.09 (0.04, 0.19) | 0.23 (0.19, 0.28) | 0.22 (0.18, 0.26) | 0.14 (0.10, 0.17) | 0.07 (0.00, 0.14) |
| England | 0.17 (0.14, 0.23) | 0.22 (0.17, 0.27) | 0.17 (0.15, 0.22) | 0.09 (0.04, 0.19) | 0.22 (0.19, 0.26) | 0.18 (0.15, 0.21) | 0.13 (0.10, 0.15) | 0.11 (0.00, 0.17) |
| United States | 0.22 (0.20, 0.30) | 0.26 (0.20, 0.31) | 0.18 (0.15, 0.23) | 0.09 (0.04, 0.19) | 0.26 (0.22, 0.31) | 0.23 (0.20, 0.26) | 0.17 (0.13, 0.20) | 0.10 (0.00, 0.16) |
Note. BMI = body mass index (defined as weight in kilograms divided by the square of height in meters); CI = confidence interval; PAF = population attributable fraction. Source of relative risks is Prospective Studies Collaboration.5 The 95% CIs for PAFs incorporate sampling uncertainty in estimates of the distribution of BMI and estimation uncertainty in relative risks of obesity.
Source. Sources and years of data are as follows: United States, National Health and Nutrition Examination Survey, cycles 2003–2004, 2005–2006, and 2007–2008; Canada, Canadian Community Health Survey, cycle 3.1 (2005); European countries excluding England, Survey of Health, Ageing and Retirement in Europe, wave 1 (2004) and refresher sample from wave 2 (2006–2007); England, English Longitudinal Study of Ageing, wave 2 (2004–2005).